Sanofi-Aventis announces R&D restructuring

Share this article:
Sanofi-Aventis announced plans to restructure its R&D model, set to be completed by 2013. 

No layoffs will result from the restructuring, according to the statement (pdf), although some 1,300 employees will be eligible for “voluntary departures,” according to the Wall Street Journal. Company locations in the UK, Japan and Spain will be closed, along with four sites in France, with a fifth being divested. 

Around 650 people will be shuffled into different locations or jobs in France, according to the statement.

“The objective of this new R&D model is to propose innovate solutions that respond to specific, unmet needs of patients and continue our success in a very competitive international environment, said Chris Viehbacher, CEO, in the statement.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...